Digestive Remedies in Japan

  • March 2015
  • -
  • Euromonitor International
  • -
  • 33 pages

Digestive remedies in Japan stagnated in current retail value terms to remain at ¥111 billion in 2014. While most of the category registered negative value growth, motion sickness remedies including paediatric products increased sales during 2014. Digestive remedies has shrunk over the years because of declining volume consumption of alcohol in Japan. More consumers in Japan are drinking less alcohol due to increasing expenditure on other leisure activities and mobile devices. Additionally,...

Euromonitor International's Digestive Remedies in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Digestive Remedies in Japan
DIGESTIVE REMEDIES IN JAPAN

March 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2009-2014
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2009-2014
Table 3 NBO Company Shares of Digestive Remedies: % Value 2010-2014
Table 4 LBN Brand Shares of Digestive Remedies: % Value 2011-2014
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2014-2019
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2014-2019
Daiichi Sankyo Healthcare Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 1 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 2 Daiichi Sankyo Healthcare Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2014
Matsumoto Kiyoshi Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 4 Matsumotokiyoshi Holdings Co Ltd: Key Facts
Summary 5 Matsumotokiyoshi Holdings Co Ltd: Operational Indicators
Company Background
Competitive Positioning
Summary 6 Matsumotokiyoshi Holdings Co Ltd: Competitive Position 2014
Taisho Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 7 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 8 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Taisho Pharmaceutical Co Ltd: Competitive Position 2014
Takeda Pharmaceutical Co Ltd in Consumer Health (japan)
Strategic Direction
Key Facts
Summary 10 Takeda Pharmaceutical Co Ltd: Key Facts
Summary 11 Takeda Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 12 Takeda Pharmaceutical Co Ltd: Competitive Position 2014
Executive Summary
Modest Positive Growth in 2014
Japanese Government Continues To Take Initiative Toward Self-medication
Competition Intensifies With New Product Launches
OTC Internet Retailing Officially Legalised
Consumer Health Expected To Register Flat Growth
Key Trends and Developments
OTC Internet Retailing Officially Legalised
Drugstores and Chemists Being Transformed To the Self-medication Platform
New Product Launches With Specific Positioning Revitalise the Market
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 13 OTC: Switches 2012-2014
Definitions
Sources
Summary 14 Research Sources












View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • November 2014
  • by Global Data

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the ...

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

  • $ 4 995
  • Industry report
  • January 2015
  • by GBI Research

Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics Summary GBI Research, the leading business intelligence provider, ...

Lymphoma Treatment Drugs Markets in China

Lymphoma Treatment Drugs Markets in China

  • $ 4 000
  • Industry report
  • December 2014
  • by Asia Market Information & Development Company

China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed ...

Global Cro Market 2015-2019

December 2014 $ 2 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.